By JOYCE THOMAS

Jackler, who also has courtesy appointments in neurosurgery and surgery, joined Stanford in July from UC-San Francisco where he was a professor of otolaryngology and of neurological surgery. He received his medical degree from Boston University School of Medicine in 1979.

His postdoctoral training included a residency in otolaryngology at UCSF and a neurotology fellowship at the House Ear Institute in Los Angeles. He is president-elect of the American Neurotology Society.

Jackler’s clinical interests are in tumors of the ear and temporal bone with a focus on surgery. He has contributed to a number of innovations designed to enhance exposure of inaccessible intracranial tumors near the brain stem. He is working with neurosurgery, radiation oncology and other departments to create a multidisciplinary center for cranial base surgery.

The professorship in otorhinolaryngology was established in 1991 with a life income gift from Edward C. Sewall, MD. Sewall, a 1902 graduate of Cooper Medical College, served as a clinical professor and chief of the eye, ear, nose and throat section when the college became the medical department of Stanford University. He later served as chief of otolaryngology until his retirement in 1940 when he achieved emeritus status. He died in 1957.

Paul A. Khavari, MD, PhD, professor of dermatology, was named the Carl J. Herzog Professor of Dermatology.

Khavari serves as chief of the dermatology section at the Veterans Affairs Palo Alto Health Care System. His lab is based at the Center for Clinical Sciences Research. A 1983 alumnus of Stanford, he received his medical degree in 1988 from Yale and trained in internal medicine and dermatology at Yale-New Haven Hospital. Khavari returned here to study gene regulation and in 1993 earned a PhD and a faculty appointment as assistant professor. He was promoted to associate professor of dermatology, with tenure, in 1998.

His research focuses on the development of new molecular therapeutics in stratified epithelial tissues and on gene regulatory control of epithelial growth and carcinogenesis. His work in molecular therapeutics is designed to bring new genetic insights to the treatment of human skin disease. He was elected to the American Society for Clinical Investigation in 1999 and received an American Dermatological Association Young Leadership Award in 2001. He is a co-founder of the Program in Epithelial Biology at Stanford.

The professorship in dermatology was established in 1989 by the Carl J. Herzog Foundation to enhance basic and multidisciplinary scientific research in the field. Carl Herzog, PhD, was born and educated in Germany, where he studied chemistry. He came to the United States before World War I and founded Duke Laboratories Inc. a decade later. Herzog, who died in 1980, had a long association with Stanford’s dermatology department and helped support its teaching and research.